HER3-Targeted Antibody-Drug Conjugate Demonstrates Potential Against Treatment-Resistant Solid Tumors
A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310. ...
